RTOG 9003: legacies of a landmark trial
- PMID: 25304786
- PMCID: PMC5823512
- DOI: 10.1016/j.ijrobp.2014.07.022
RTOG 9003: legacies of a landmark trial
Conflict of interest statement
Conflict of Interest: none
References
-
- Feigenberg S, Patel K, Amdur RJ, et al. Rtog 90-03: The untold story. Red. In Press. - PubMed
-
- Foray N. Claudius regaud (1870–1940): A pioneer of radiobiology and radiotherapy. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 2012;16:315–321. - PubMed
-
- Marcial VA, Pajak TF, Chang C, et al. Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the radiation therapy oncology group (rtog) Red. 1987;13:41–47. - PubMed
-
- Cox JD, Pajak TF, Marcial VA, et al. Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: Preliminary report of radiation therapy oncology group protocol 83-13. Red. 1990;18:515–521. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
